Physician

John P Barletta, M.D.

According to 2025 Medicare claims, John Barletta, M.D. (NPI: 1073576039) practices ophthalmology in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is BLUE SKY VISION EYE CARE, P.C (NPI: 1801977202; TIN: 38-2394920) and primary practice location at 48197-1102.

Barletta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 923 traditional Medicare patients, billed 1,998 HCPCS/CPT codes, and received $177,252 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,293 prescription claims across 469 beneficiaries totaling $584,325 in drug costs, led by Oxervate (Cenegermin-Bkbj). DME data shows 22 claims. Open Payments data shows 20 records totaling $542. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $224,940 and ending at $584,325. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,258	2,630	$260,998
2016	1,268	2,754	$280,471
2017	1,176	2,538	$243,131
2018	1,185	2,590	$269,086
2019	1,208	2,485	$255,051
2020	966	2,088	$186,234
2021	970	2,231	$215,178
2022	1,051	2,484	$219,646
2023	1,074	2,336	$204,230
2024	923	1,998	$177,252

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	474	1,943	$224,940
2016	494	1,894	$260,137
2017	517	1,818	$234,473
2018	530	1,663	$590,520
2019	477	1,465	$816,702
2020	369	1,101	$210,358
2021	359	1,053	$230,747
2022	413	1,132	$251,989
2023	401	1,132	$292,750
2024	469	1,293	$584,325

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	38	40	$2,629
2016	26	37	$2,389
2017	44	44	$2,726
2018	27	27	$1,840
2019	47	47	$3,207
2020	24	25	$1,624
2021	37	37	$2,308
2022	16	16	$989
2023	N/R	N/R	N/R
2024	11	22	$1,748

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	286	454	$90
92014	Established patient complete exam of visual system	577	608	$82
92083	Exam of visual field with extended testing	98	102	$42
92134	Imaging of retina	126	129	$28
92133	Imaging of optic nerve	79	80	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxervate	Cenegermin-Bkbj	11	154	$392,181
Restasis	Cyclosporine	38	2,880	$55,880
Xiidra	Lifitegrast	18	1,560	$34,099
Cyclosporine	Cyclosporine	39	3,330	$26,348
Prednisolone Acetate	Prednisolone Acetate	196	11,138	$10,487

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	N/R	11	$1,126
V2020	Frames, purchases	N	11	11	$622

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$542	Tarsus Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John P. Barletta, M.D.?

Tedicare shows public-source Medicare data for John P. Barletta, M.D. (NPI 1073576039), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John P. Barletta, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John P. Barletta, M.D.?

John P. Barletta, M.D. is linked to BLUE SKY VISION EYE CARE, P.C (billing NPI 1801977202) in the available physician profile data.

Does John P. Barletta, M.D. have Open Payments data?

John P. Barletta, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.